{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:37:59Z","timestamp":1793644679021,"version":"4.5.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/wnf.0b013e318064579f","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T23:55:28Z","timestamp":1236210928000},"page":"326-334","source":"Crossref","is-referenced-by-count":47,"title":["A Naturalistic Long-Term Comparison Study of Selective Serotonin Reuptake Inhibitors in the Treatment of Panic Disorder"],"prefix":"10.1097","volume":"30","author":[{"given":"Pinhas N.","family":"Dannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulian","family":"Iancu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lowengrub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehudit","family":"Gonopolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Musin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Grunhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-2-20210203","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0033-3182(99)71207-7","article-title":"Effects of psychological intervention on panic attack patients in the emergency department.","volume":"40","author":"Dyckman","year":"1999","journal-title":"Psychosomatics"},{"key":"R3-2-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1192\/S0007125000293355","article-title":"The social costs of anxiety disorders.","volume":"166","author":"Leon","year":"1995","journal-title":"Br J Psychiatry Suppl"},{"key":"R5-2-20210203","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1192\/S0007125000293367","article-title":"Costs and offset effects in panic disorders.","volume":"166","author":"Salvador-Carulla","year":"1995","journal-title":"Br J Psychiatry Suppl"},{"key":"R6-2-20210203","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States.","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"R7-2-20210203","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0193-953X(18)30023-6","article-title":"The longitudinal course and outcome of panic disorder.","volume":"18","author":"Pollack","year":"1995","journal-title":"Psychiatr Clin North Am"},{"key":"R8-2-20210203","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archpsyc.1997.01830160021003","article-title":"The cross-national epidemiology of panic disorder.","volume":"54","author":"Weissman","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"R10-2-20210203","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial.","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"key":"R11-2-20210203","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1176\/ajp.152.5.673","article-title":"Imipramine treatment of panic disorder with agoraphobia.","volume":"152","author":"Mavissakalian","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R13-2-20210203","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","article-title":"Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.","volume":"45","author":"Ballenger","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"R14-2-20210203","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/ajp.144.3.303","article-title":"Discontinuation of alprazolam treatment in panic patients.","volume":"144","author":"Fyer","year":"1987","journal-title":"Am J Psychiatry"},{"key":"R16-2-20210203","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2001-14283","article-title":"A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.","volume":"34","author":"Perna","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"R17-2-20210203","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00004714-200010000-00011","article-title":"Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial.","volume":"20","author":"Hirschmann","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R18-2-20210203","first-page":"993","article-title":"Visual analog scales.","volume":"62","author":"Zeally","year":"1969","journal-title":"Proc R Soc Med"},{"key":"R20-2-20210203","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4088\/JCP.v63n0414","article-title":"Prevalence of sexual dysfunction among newer antidepressants.","volume":"63","author":"Clayton","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R21-2-20210203","first-page":"755","article-title":"Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush sexual inventory.","volume":"33","author":"Zajecka","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"R22-2-20210203","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1192\/bjp.170.6.549","article-title":"The effect of citalopram in panic disorder.","volume":"170","author":"Wade","year":"1997","journal-title":"Br J Psychiatry"},{"key":"R23-2-20210203","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4088\/JCP.v59n1006","article-title":"A controlled, prospective, one-year trial of citalopram in the treatment of panic disorder.","volume":"59","author":"Lepola","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R24-2-20210203","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1176\/ajp.155.11.1570","article-title":"The Fluoxetine Panic Disorder Study Group. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo.","volume":"155","author":"Michelson","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R25-2-20210203","first-page":"1570","article-title":"The Fluoxetine Panic Disorder Study Group. Continuing treatment of panic disorder after acute response: randomized, placebo-controlled trial with fluoxetine.","volume":"155","author":"Michelson","year":"1999","journal-title":"Br J Psychiatr"},{"key":"R26-2-20210203","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.179.6.514","article-title":"Efficacy of usual antidepressant dosing regimen of fluoxetine in panic disorder: randomized, placebo-controlled trial.","volume":"179","author":"Michelson","year":"2001","journal-title":"Br J Psychiatry"},{"key":"R27-2-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4088\/JCP.v60n0505","article-title":"Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder.","volume":"60","author":"Emmanuel","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R28-2-20210203","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archpsyc.1993.01820130046008","article-title":"Comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder.","volume":"50","author":"Black","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"R29-2-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(01)00265-7","article-title":"Fluvoxamine in the treatment of panic disorder: a multicenter, double-blind, placebo-controlled study in outpatients.","volume":"103","author":"Asnis","year":"2001","journal-title":"Psychiatry Res"},{"key":"R30-2-20210203","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.167.3.374","article-title":"Paroxetine in the treatment of panic disorder. A randomised, double blind, placebo-controlled study.","volume":"167","author":"Oehrberg","year":"1995","journal-title":"Br J Psychiatry"},{"key":"R31-2-20210203","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1176\/ajp.155.1.36","article-title":"Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.","volume":"155","author":"Ballenger","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R32-2-20210203","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4088\/JCP.v60n1205","article-title":"Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.","volume":"60","author":"Bakkar","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R33-2-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0447.1997.tb00388.x","article-title":"A comparison of paroxetine, clompiramine and placebo in the treatment of panic disorder.","volume":"95","author":"Lecrubier","year":"1997","journal-title":"Acta Psychiatr Scand"},{"key":"R34-2-20210203","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1034\/j.1600-0447.2002.02255.x","article-title":"SSRIs versus TCAs in the treatment of panic disorder: a meta-analysis.","volume":"106","author":"Bakker","year":"2002","journal-title":"Acta Psychiatr Scand"},{"issue":"suppl 8","key":"R35-2-20210203","first-page":"17","article-title":"The long-term treatment of panic disorder.","volume":"59","author":"Davidson","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R36-2-20210203","first-page":"4","article-title":"Three year naturalistic outcome study of panic disorder patients treated with paroxetine.","volume":"11","author":"Dannon","year":"2004","journal-title":"BMC Psychiatry"},{"key":"R37-2-20210203","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4088\/JCP.v61n0406","article-title":"Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.","volume":"61","author":"Kennedy","year":"2000","journal-title":"J Clin Psychiatry"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002826-200711000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:51:28Z","timestamp":1618278688000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-200711000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e318064579f","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}